CannabisNewsBreaks – Genius One, Inc. Announces Findings in Evaluating Cannabis as Potential Treatment of COVID -19 Complications

April 20, 2020 12:16:03

Genius One announced today that, due to the recent COVID-19 (SARS-CoV-2) virus outbreak and the resulting worldwide pandemic, it determined to research and study potential treatment of life-threatening cases. “Because Genius is an avid member of the cannabis movement and industry, when we were looking at possible solutions, we naturally evaluated the cannabis plant along with various cannabinoids, including Delta-9 and CBDs,” Genius CEO Dyan Ferman stated in the news release. “Our study focused on one main question: How can cannabinoids help in treatment of the virus, as well as virus-related complications and effects?”

About Genius One, Inc.

Genius is a provider of a multifunctional device, Genius pipes, which are designed for flower and oil consumption and used by modern consumers around the world for enhanced taste and a unique user experience. For more information, visit

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.